Bank Nifty appears more exhausted, prompting to be cautious, says Geojit Financial Services

By Anand James

Though Monday’s opening gains could not be sustained, and upsides kept getting capped through the rest of the week, there was a marked departure from the previous week’s sell-on-rallies mode with the market witnessing a buy-on-dips approach. As a result, though benchmark indices may not have much to show on the board, a broad market recovery appears to be in play. Meanwhile, 83% of NSE 500 stocks closed above their respective 10-day SMA on Friday, when compared to just 35% on the previous Friday, and more than 63% of the constituent stocks bounced at least 1% from Friday’s lows, confirming strength across the board.

Nifty appears rejuvenated after last week’s consolidation

Last week, while turning bullish and setting a target of 25262, we were clear of the prospects of a turn lower prior to that. The recovery post expiry, from the 23900 vicinity is suggestive of regrouping of bulls. We are encouraged to eye 24700, the 50-day SMA, as the near-term objective. Alternatively, the inability to float above 24230 early in the week, could see Nifty drifting lower again, hoping for 23700 to attract bargain buying again and a regrouping of bulls. Meanwhile, Bank Nifty appears more travel weary and exhausted, prompting us to be cautious on approach to 52500. However, if we get a time correction with dips not extending past 51400, a stronger upside could unfold with upside objectives stretched to 53700.

Sectoral Cues

Pharma to gain strength

Nifty Pharma Index has been in a pullback mode since October 2024 and seems to have formed a base around 21500 and a reversal is underway on the weekly scale. The Stochastic Momentum histogram has shown signs of exhaustion at lower levels on the weekly scale and the stock has bounced off the Supertrend level of 21500 hinting at the continuation of the ongoing reversal. Expect the current reversal to push the index towards 22750-22950 in the near term. Aurobindo Pharma, Sun Pharma, Cipla, Zyduslife, Divi’s Lab, Torrent Pharma and Alkem Lab are expected to lead the index.

Reversal seen in Oil & Gas

The Nifty Oil & Gas index has been on a decline since August 2024 and has seen a Morning Star candlestick pattern in the weekly time frame indicating the start of a reversal. The Stochastic Momentum histogram has shown signs of exhaustion at lower levels on the weekly scale and stock is close to breaking above the Supertrend level in the daily time frame.

 » Read More

Related Articles

Why you need to be mindful of asset allocation in 2025 and beyond

An old Spanish novel, Don Quixote by Miguel de Cervantes, carries a pearl of wisdom: “It is the part of a wise man to keep himself today for tomorrow, and not to venture all his eggs in one basket”. The hidden piece of advice in not putting all your eggs in one basket is averting

Top 5 cheapest stocks in India

By Ekta Sonecha Desai In periods of swift market corrections, investors tend to examine valuation metrics to determine if stocks have gotten cheap compared to their fundamentals. One of the most common metrics is the Price-to-Earnings (P/E) ratio, which measures a company’s stock price versus its earnings per share (EPS). A low P/E ratio may

Indian wines stay robust amid global concerns

Amid a global supply glut, difficult weather and falling demand worldwide, which has hit a 27-year low (as per a World Spirits Alliance report), Indian wines continue to show signs of resilience and adaptability, with insiders anticipating the market to grow by as much as 10-15% in the next 3-5 years. At the forefront of

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Why you need to be mindful of asset allocation in 2025 and beyond

An old Spanish novel, Don Quixote by Miguel de Cervantes, carries a pearl of wisdom: “It is the part of a wise man to keep himself today for tomorrow, and not to venture all his eggs in one basket”. The hidden piece of advice in not putting all your eggs in one basket is averting

Top 5 cheapest stocks in India

By Ekta Sonecha Desai In periods of swift market corrections, investors tend to examine valuation metrics to determine if stocks have gotten cheap compared to their fundamentals. One of the most common metrics is the Price-to-Earnings (P/E) ratio, which measures a company’s stock price versus its earnings per share (EPS). A low P/E ratio may

Indian wines stay robust amid global concerns

Amid a global supply glut, difficult weather and falling demand worldwide, which has hit a 27-year low (as per a World Spirits Alliance report), Indian wines continue to show signs of resilience and adaptability, with insiders anticipating the market to grow by as much as 10-15% in the next 3-5 years. At the forefront of

Warren Buffett says Berkshire Hathaway paid more taxes to US govt than American tech titans

Berkshire Hathaway chairman and CEO Warren E Buffett, in a letter to shareholders, said that the company has paid more in corporate income tax than the US government had ever received from any company or even the American tech titans that commanded market values in the trillions.  Warren Buffett highlighted that the company paid $26.8

4 reasons Warren Buffett is betting on Treasuries, Stocks

In his letter to the shareholders of Berkshire Hathaway, Warren Buffett listed the key contributors to Berkshire’s performance in 2024. This was largely due to the improvement in Treasury Bill yields, increase in earnings of insurance companies, higher share of equity investments, bargain buys in equity markets and investment in fundamentally good businesses. “Berkshire will